Illumina Statistics and Revenue Totals (2023)
Last Updated on: May 25th, 2023
Here are a few of the most interesting Illumina statistics I was able to dig up including Illumina revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Illumina Facts
- Website: Official Website
- Year Founded: 1998
- Headquarters: San Diego, CA
- Founder(s): David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik and Mark Chee
- Current Chief Executive: Francis deSouza
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. (source)
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. (Illumina Statistics
Illumina Revenue Totals
Illumina annual revenue:
- 2022: $4.58 billion
- 2021: $4.526 billion
- 2020: $3.239 billion
- 2019: $3.543 billion
- 2018: $3.333 billion
- 2017: $2.752 billion
- 2016: $2.398 billion
- 2015: $2.220 billion
Illumina annual net income:
- 2022: $4.404 billion net loss
- 2021: $762 million
- 2020: $656 million
- 2019: $990 million
- 2018: $782 million
- 2017: $678 million
- 2016: $428 million
- 2015: $458 million
Additional Illumina Statistics
Number of Illumina patents:
799 issued US patents and 617 pending US patent applications
Last updated 1/16/20
Please note that some of these numbers are easier to find than others. A few of these Illumina statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags:
